Reshaping the HIV treatment and prevention landscape

Maximising opportunities in prevention and treatment Vaccines and Specialty Medicines Increasing number of synergies across prevention and treatment... - - Immune dysfunction contributes to pathophysiology of many diseases with scientific understanding rapidly evolving Convergence of modalities to prevent and treat disease ...provides significant opportunity and advantage for New GSK - - - - - - R&D focus on science of immune system, human genetics and advanced technologies Immuno-modulators >70% of clinical pipeline World leader in infectious diseases One capital allocation process - Integrated Development and Commercial Unrivalled suite of platform technologies Attractive portfolio offering to payors gsk > > > > > > 16

View entire presentation